Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
Clinical trial NCT00469690 · COMPLETED
Trial details
- NCT number
- NCT00469690
- Sponsor
- Innovative Medical
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.